Enterobiotix
PrivateLast Round
Seed Round
Apr 9, 2026
Total Funding Raised
$59.03M
Company Overview
EnteroBiotix is a biotechnology company that develops microbiome-modulating drugs aimed at restoring health and preventing bacterial infections through tailored high-diversity microbial therapeutics for patients with serious unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enterobiotix Comps
Public and private peers based on sector, stage, and business model.
Enterobiotix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 9, 2026 | ||||
| Early Funding | Apr 4, 2024 | ||||
| Series A | Sep 7, 2021 | ||||
| Seed | May 29, 2019 | ||||
| Grant | Jun 21, 2017 | ||||
Seed | Jun 21, 2017 |
Key People
Founding team and executive leadership
Enterobiotix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kineticos Disruptor Fund | Series A, Early Funding |
| University of Aberdeen | Seed |
| Gabriel Investments Ltd | Seed |
| Kineticos Ventures | Series A, Early Funding |
| Equity Gap | Early Funding, Seed |
| Scottish EDGE | Grant |
| Scottish National Investment Bank | Seed, Series A, Early Funding, Seed Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Lead candidate EBX-102-02 advances to Phase 2b for IBS-C treatment.
- Apr 9, 2026
Raised $5.3M in a Seed Round.
Enterobiotix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enterobiotix's valuation, stock price, and market status.
